发布者：Primerbank 时间：2017-10-09 浏览量：3406
|
|
Description |
| 1 | v-abl Abelson murine leukemia viral oncogene homolog 1 |
| 2 | adenosine A1 receptor |
| 3 | adenosine A2a receptor |
| 4 | poly (ADP-ribose) polymerase family, member 1 |
| 5 | poly (ADP-ribose) polymerase family, member 4 |
| 6 | adrenergic, alpha-1A-, receptor |
| 7 | angiotensin II receptor, type 2 |
| 8 | aryl hydrocarbon receptor |
| 9 | allograft inflammatory factor 1 |
| 10 | v-akt murine thymoma viral oncogene homolog 1 |
| 11 | v-akt murine thymoma viral oncogene homolog 2 |
| 12 | arachidonate 12-lipoxygenase |
| 13 | apoptotic peptidase activating factor 1 |
| 14 | nudix (nucleoside diphosphate linked moiety X)-type motif 2 |
| 15 | APEX nuclease (multifunctional DNA repair enzyme) 1 |
| 16 | baculoviral IAP repeat-containing 2 |
| 17 | baculoviral IAP repeat-containing 3 |
| 18 | baculoviral IAP repeat-containing 4 |
| 19 | baculoviral IAP repeat-containing 5 (survivin) |
| 20 | amyloid beta (A4) precursor-like protein 1 |
| 21 | amyloid beta (A4) precursor protein (peptidase nexin-II, Alzheimer disease) |
| 22 | Fas (TNF receptor superfamily, member 6) |
| 23 | Fas ligand (TNF superfamily, member 6) |
| 24 | ras homolog gene family, member A |
| 25 | ras homolog gene family, member B |
| 26 | ataxia telangiectasia mutated (includes complementation groups A, C and D) |
| 27 | BCL2-antagonist of cell death |
| 28 | BCL2-associated athanogene |
| 29 | BCL2-antagonist/killer 1 |
| 30 | BRCA1 associated RING domain 1 |
| 31 | BCL2-associated X protein |
| 32 | B-cell CLL/lymphoma 2 |
| 33 | BCL2-related protein A1 |
| 34 | BCL2-like 1 |
| 35 | BCL2-like 2 |
| 36 | B-cell CLL/lymphoma 3 |
| 37 | B-cell CLL/lymphoma 6 (zinc finger protein 51) |
| 38 | tumor necrosis factor receptor superfamily, member 17 |
| 39 | brain-derived neurotrophic factor |
| 40 | BH3 interacting domain death agonist |
| 41 | BCL2-interacting killer (apoptosis-inducing) |
| 42 | bone morphogenetic protein 4 |
| 43 | BCL2/adenovirus E1B 19kDa interacting protein 1 |
| 44 | BCL2/adenovirus E1B 19kDa interacting protein 2 |
| 45 | BCL2/adenovirus E1B 19kDa interacting protein 3 |
| 46 | BCL2-related ovarian killer |
| 47 | breast cancer 1, early onset |
| 48 | v-raf murine sarcoma viral oncogene homolog B1 |
| 49 | Bruton agammaglobulinemia tyrosine kinase |
| 50 | complement component 5 |
| 51 | complement component 6 |
| 52 | complement component 7 |
| 53 | complement component 8, alpha polypeptide |
| 54 | complement component 8, beta polypeptide |
| 55 | complement component 8, gamma polypeptide |
| 56 | complement component 9 |
| 57 | calpain 1, (mu/I) large subunit |
| 58 | calpain 6 |
| 59 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) |
| 60 | caspase 2, apoptosis-related cysteine peptidase (neural precursor cell expressed, developmentally down-regulated 2) |
| 61 | caspase 3, apoptosis-related cysteine peptidase |
| 62 | caspase 4, apoptosis-related cysteine peptidase |
| 63 | caspase 5, apoptosis-related cysteine peptidase |
| 64 | caspase 6, apoptosis-related cysteine peptidase |
| 65 | caspase 7, apoptosis-related cysteine peptidase |
| 66 | caspase 8, apoptosis-related cysteine peptidase |
| 67 | caspase 9, apoptosis-related cysteine peptidase |
| 68 | caspase 10, apoptosis-related cysteine peptidase |
| 69 | caveolin 1, caveolae protein, 22kDa |
| 70 | caveolin 2 |
| 71 | Cas-Br-M (murine) ecotropic retroviral transforming sequence |
| 72 | CD2 molecule |
| 73 | CD5 molecule-like |
| 74 | CD14 molecule |
| 75 | CD27 molecule |
| 76 | CD28 molecule |
| 77 | tumor necrosis factor receptor superfamily, member 8 |
| 78 | tumor necrosis factor (ligand) superfamily, member 8 |
| 79 | scavenger receptor class B, member 1 |
| 80 | CD38 molecule |
| 81 | CD40 molecule, TNF receptor superfamily member 5 |
| 82 | CD40 ligand (TNF superfamily, member 5, hyper-IgM syndrome) |
| 83 | CD70 molecule |
| 84 | cell division cycle 2-like 1 (PITSLRE proteins) |
| 85 | cell division cycle 25 homolog A (S. pombe) |
| 86 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
| 87 | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) |
| 88 | cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) |
| 89 | chorionic gonadotropin, beta polypeptide |
| 90 | conserved helix-loop-helix ubiquitous kinase |
| 91 | cell death-inducing DFFA-like effector a |
| 92 | clusterin |
| 93 | ceroid-lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease) |
| 94 | cannabinoid receptor 1 (brain) |
| 95 | cannabinoid receptor 2 (macrophage) |
| 96 | ciliary neurotrophic factor |
| 97 | mitogen-activated protein kinase 14 |
| 98 | CSE1 chromosome segregation 1-like (yeast) |
| 99 | catenin (cadherin-associated protein), beta 1, 88kDa |
| 100 | cathepsin D |
| 101 | cytochrome c-1 |
| 102 | defender against cell death 1 |
| 103 | death-associated protein |
| 104 | death-associated protein kinase 1 |
| 105 | death-associated protein kinase 3 |
| 106 | death-associated protein 6 |
| 107 | deleted in colorectal carcinoma |
| 108 | growth arrest and DNA-damage-inducible, alpha |
| 109 | DNA-damage-inducible transcript 3 |
| 110 | DNA fragmentation factor, 45kDa, alpha polypeptide |
| 111 | DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase) |
| 112 | deoxyribonuclease I |
| 113 | deoxyribonuclease I-like 3 |
| 114 | deoxyribonuclease II, lysosomal |
| 115 | dedicator of cytokinesis 1 |
| 116 | dual specificity phosphatase 6 |
| 117 | dual specificity phosphatase 7 |
| 118 | E2F transcription factor 1 |
| 119 | E2F transcription factor 3 |
| 120 | E2F transcription factor 5, p130-binding |
| 121 | eukaryotic translation initiation factor 4 gamma, 2 |
| 122 | epithelial membrane protein 1 |
| 123 | epithelial membrane protein 2 |
| 124 | epithelial membrane protein 3 |
| 125 | E1A binding protein p300 |
| 126 | excision repair cross-complementing rodent repair deficiency, complementation group 2 (xeroderma pigmentosum D) |
| 127 |
excision repair cross- complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing) |
| 128 | endoplasmic reticulum to nucleus signalling 1 |
| 129 | coagulation factor II (thrombin) |
| 130 | coagulation factor II (thrombin) receptor |
| 131 | Fanconi anemia, complementation group A |
| 132 | PTK2B protein tyrosine kinase 2 beta |
| 133 | c-fos induced growth factor (vascular endothelial growth factor D) |
| 134 | forkhead box O1 |
| 135 | forkhead box O3 |
| 136 | FOS-like antigen 2 |
| 137 | GRB2-associated binding protein 1 |
| 138 | growth arrest-specific 2 |
| 139 | glial cell derived neurotrophic factor |
| 140 | GPI anchored molecule like protein |
| 141 | glutathione peroxidase 1 |
| 142 | glutathione peroxidase 4 (phospholipid hydroperoxidase) |
| 143 | growth factor receptor-bound protein 2 |
| 144 | glycogen synthase kinase 3 beta |
| 145 | gelsolin (amyloidosis, Finnish type) |
| 146 | glutathione reductase |
| 147 | glutathione S-transferase M1 |
| 148 | glutathione S-transferase pi |
| 149 | glutathione S-transferase theta 2 |
| 150 | granzyme H (cathepsin G-like 2, protein h-CCPX) |
| 151 | granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) |
| 152 | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
| 153 | granzyme M (lymphocyte met-ase 1) |
| 154 | huntingtin (Huntington disease) |
| 155 | histone deacetylase 1 |
| 156 | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
| 157 | heat shock 10kDa protein 1 (chaperonin 10) |
| 158 | islet amyloid polypeptide |
| 159 | interferon, alpha 2 |
| 160 | interferon, beta 1, fibroblast |
| 161 | insulin-like growth factor 1 receptor |
| 162 | insulin-like growth factor 2 (somatomedin A) |
| 163 | insulin-like growth factor 2 receptor |
| 164 | insulin-like growth factor binding protein, acid labile subunit |
| 165 | insulin-like growth factor binding protein 2, 36kDa |
| 166 | insulin-like growth factor binding protein 4 |
| 167 | insulin-like growth factor binding protein 5 |
| 168 | insulin-like growth factor binding protein 6 |
| 169 | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
| 170 | interleukin 1, alpha |
| 171 | interleukin 1, beta |
| 172 | interleukin 2 |
| 173 | interleukin 2 receptor, alpha |
| 174 | interleukin 3 (colony-stimulating factor, multiple) |
| 175 | interleukin 3 receptor, alpha (low affinity) |
| 176 | interleukin 10 |
| 177 | interleukin 10 receptor, beta |
| 178 | tumor necrosis factor receptor superfamily, member 9 |
| 179 | interleukin 17A |
| 180 | forkhead box K2 |
| 181 | interferon regulatory factor 1 |
| 182 | jun oncogene |
| 183 | jun B proto-oncogene |
| 184 | jun D proto-oncogene |
| 185 | lactalbumin, alpha- |
| 186 | lectin, galactoside-binding, soluble, 1 (galectin 1) |
| 187 | LIM and senescent cell antigen-like domains 1 |
| 188 | lymphotoxin alpha (TNF superfamily, member 1) |
| 189 | lymphotoxin beta (TNF superfamily, member 3) |
| 190 | lymphotoxin beta receptor (TNFR superfamily, member 3) |
| 191 | CD180 molecule |
| 192 | lysozyme (renal amyloidosis) |
| 193 | microtubule-associated protein tau |
| 194 | myeloid cell leukemia sequence 1 (BCL2-related) |
| 195 | Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) |
| 196 | Mdm4, transformed 3T3 cell double minute 4, p53 binding protein (mouse) |
| 197 | mitogen-activated protein kinase kinase kinase 1 |
| 198 | mitogen-activated protein kinase kinase kinase 3 |
| 199 | mitogen-activated protein kinase kinase kinase 5 |
| 200 | mitogen-activated protein kinase kinase kinase 10 |
| 201 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
| 202 | myeloperoxidase |
| 203 | myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
| 204 | v-myb myeloblastosis viral oncogene homolog (avian) |
| 205 | v-myb myeloblastosis viral oncogene homolog (avian)-like 2 |
| 206 | v-myc myelocytomatosis viral oncogene homolog (avian) |
| 207 | growth arrest and DNA-damage-inducible, beta |
| 208 | NLR family, apoptosis inhibitory protein |
| 209 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105) |
| 210 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
| 211 | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
| 212 | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta |
| 213 | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon |
| 214 | nerve growth factor, beta polypeptide |
| 215 | nerve growth factor receptor (TNFR superfamily, member 16) |
| 216 | non-metastatic cells 3, protein expressed in |
| 217 | nitric oxide synthase 1 (neuronal) |
| 218 | nitric oxide synthase 2A (inducible, hepatocytes) |
| 219 | nucleophosmin (nucleolar phosphoprotein B23, numatrin) |
| 220 | neurotrophin 3 |
| 221 | neurotrophic tyrosine kinase, receptor, type 1 |
| 222 | tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) |
| 223 | purinergic receptor P2X, ligand-gated ion channel, 1 |
| 224 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
| 225 | p21/Cdc42/Rac1-activated kinase 1 (STE20 homolog, yeast) |
| 226 | p21 (CDKN1A)-activated kinase 2 |
| 227 | PRKC, apoptosis, WT1, regulator |
| 228 | paired box gene 3 (Waardenburg syndrome 1) |
| 229 | paired box gene 7 |
| 230 | programmed cell death 1 |
| 231 | programmed cell death 2 |
| 232 | phosphodiesterase 1B, calmodulin-dependent |
| 233 | phosphoinositide-3-kinase, class 2, gamma polypeptide |
| 234 | phorbol-12-myristate-13-acetate-induced protein 1 |
| 235 | promyelocytic leukemia |
| 236 | P450 (cytochrome) oxidoreductase |
| 237 | protein phosphatase 2 (formerly 2A), regulatory subunit A, beta isoform |
| 238 | perforin 1 (pore forming protein) |
| 239 | protein kinase, AMP-activated, alpha 1 catalytic subunit |
| 240 | protein kinase C, alpha |
| 241 | protein kinase C, epsilon |
| 242 | protein kinase C, zeta |
| 243 | mitogen-activated protein kinase 1 |
| 244 | mitogen-activated protein kinase 4 |
| 245 | mitogen-activated protein kinase 7 |
| 246 | mitogen-activated protein kinase 8 |
| 247 | mitogen-activated protein kinase 10 |
| 248 | mitogen-activated protein kinase kinase 1 |
| 249 | mitogen-activated protein kinase kinase 5 |
| 250 | mitogen-activated protein kinase kinase 6 |
| 251 | eukaryotic translation initiation factor 2-alpha kinase 2 |
| 252 | presenilin 1 (Alzheimer disease 3) |
| 253 | presenilin 2 (Alzheimer disease 4) |
| 254 | phosphatase and tensin homolog (mutated in multiple advanced cancers 1) |
| 255 | prostaglandin E receptor 3 (subtype EP3) |
| 256 | parathyroid hormone |
| 257 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
| 258 | PTK2 protein tyrosine kinase 2 |
| 259 | protein tyrosine phosphatase, non-receptor type 6 |
| 260 | protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase) |
| 261 | RAD21 homolog (S. pombe) |
| 262 | RAD23 homolog B (S. cerevisiae) |
| 263 | v-raf-1 murine leukemia viral oncogene homolog 1 |
| 264 | retinoblastoma 1 (including osteosarcoma) |
| 265 | AT rich interactive domain 4A (RBP1-like) |
| 266 | jumonji, AT rich interactive domain 1A |
| 267 | retinoblastoma binding protein 4 |
| 268 | retinoblastoma binding protein 5 |
| 269 | retinoblastoma binding protein 6 |
| 270 | retinoblastoma-like 1 (p107) |
| 271 | retinoblastoma-like 2 (p130) |
| 272 | v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappa light polypeptide gene enhancer in B- cells 3, p65 (avian) |
| 273 | v-rel reticuloendotheliosis viral oncogene homolog B, nuclear factor of kappa light polypeptide gene enhancer in B- cells 3 (avian) |
| 274 | D4, zinc and double PHD fingers family 2 |
| 275 | S100 calcium binding protein B |
| 276 | mitogen-activated protein kinase 12 |
| 277 | chemokine (C-C motif) ligand 2 |
| 278 | mitogen-activated protein kinase kinase 4 |
| 279 | secreted frizzled-related protein 1 |
| 280 | secreted frizzled-related protein 2 |
| 281 | secreted frizzled-related protein 5 |
| 282 | serum/glucocorticoid regulated kinase |
| 283 | seven in absentia homolog 1 (Drosophila) |
| 284 | signal-induced proliferation-associated gene 1 |
| 285 | synuclein, alpha (non A4 component of amyloid precursor) |
| 286 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) |
| 287 | SON DNA binding protein |
| 288 | secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1) |
| 289 | somatostatin receptor 3 |
| 290 | signal transducer and activator of transcription 1, 91kDa |
| 291 | serine/threonine kinase 3 (STE20 homolog, yeast) |
| 292 | ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) |
| 293 | mitogen-activated protein kinase kinase kinase 7 |
| 294 | teratocarcinoma-derived growth factor 1 |
| 295 | testis enhanced gene transcript (BAX inhibitor 1) |
| 296 | transcription factor Dp-1 |
| 297 | transcription factor Dp-2 (E2F dimerization partner 2) |
| 298 | transforming growth factor, beta 1 |
| 299 | TIA1 cytotoxic granule-associated RNA binding protein |
| 300 | TIA1 cytotoxic granule-associated RNA binding protein-like 1 |
| 301 | TIMP metallopeptidase inhibitor 3 (Sorsby fundus dystrophy, pseudoinflammatory) |
| 302 | toll-like receptor 2 |
| 303 | claudin 5 (transmembrane protein deleted in velocardiofacial syndrome) |
| 304 | tumor necrosis factor (TNF superfamily, member 2) |
| 305 | tumor necrosis factor, alpha-induced protein 1 (endothelial) |
| 306 | tumor necrosis factor, alpha-induced protein 2 |
| 307 | tumor necrosis factor, alpha-induced protein 3 |
| 308 | tumor necrosis factor, alpha-induced protein 6 |
| 309 | tumor necrosis factor receptor superfamily, member 1A |
| 310 | tumor necrosis factor receptor superfamily, member 1B |
| 311 | tumor protein p53 (Li-Fraumeni syndrome) |
| 312 | tumor protein p53 binding protein, 2 |
| 313 | tumor protein p73 |
| 314 | heat shock protein 90kDa beta (Grp94), member 1 |
| 315 | TNF receptor-associated factor 1 |
| 316 | TNF receptor-associated factor 2 |
| 317 | TNF receptor-associated factor 3 |
| 318 | TNF receptor-associated factor 5 |
| 319 | TNF receptor-associated factor 6 |
| 320 | pleckstrin homology-like domain, family A, member 2 |
| 321 | tumor necrosis factor (ligand) superfamily, member 4 (tax-transcriptionally activated glycoprotein 1, 34kDa) |
| 322 | tumor necrosis factor receptor superfamily, member 4 |
| 323 | voltage-dependent anion channel 1 |
| 324 | vascular endothelial growth factor B |
| 325 | vascular endothelial growth factor C |
| 326 | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide |
| 327 | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide |
| 328 | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide |
| 329 | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide |
| 330 | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide |
| 331 | death associated protein 3 |
| 332 | cullin 5 |
| 333 | fragile X mental retardation, autosomal homolog 1 |
| 334 | D4, zinc and double PHD fingers family 1 |
| 335 | non-metastatic cells 5, protein expressed in (nucleoside-diphosphate kinase) |
| 336 | cullin 4A |
| 337 | cullin 3 |
| 338 | cullin 2 |
| 339 | cullin 1 |
| 340 | G protein-coupled receptor 65 |
| 341 | ectodermal-neural cortex (with BTB-like domain) |
| 342 | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma |
| 343 | chromobox homolog 4 (Pc class homolog, Drosophila) |
| 344 | apoptosis inhibitor 5 |
| 345 | tyrosyl-tRNA synthetase |
| 346 | MAP-kinase activating death domain |
| 347 | tumor necrosis factor (ligand) superfamily, member 11 |
| 348 | tumor protein p73-like |
| 349 | beclin 1 (coiled-coil, myosin-like BCL2 interacting protein) |
| 350 | TNFRSF1A-associated via death domain |
| 351 | tumor necrosis factor receptor superfamily, member 25 |
| 352 | catenin (cadherin-associated protein), alpha-like 1 |
| 353 | receptor (TNFRSF)-interacting serine-threonine kinase 1 |
| 354 | CASP2 and RIPK1 domain containing adaptor with death domain |
| 355 | harakiri, BCL2 interacting protein (contains only BH3 domain) |
| 356 | tumor necrosis factor (ligand) superfamily, member 14 |
| 357 | tumor necrosis factor (ligand) superfamily, member 13 |
| 358 | tumor necrosis factor (ligand) superfamily, member 12 |
| 359 | tumor necrosis factor (ligand) superfamily, member 10 |
| 360 | tumor necrosis factor (ligand) superfamily, member 9 |
| 361 | tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) |
| 362 | receptor-interacting serine-threonine kinase 2 |
| 363 | tumor necrosis factor receptor superfamily, member 6b, decoy |
| 364 | Fas (TNFRSF6)-associated via death domain |
| 365 | tumor necrosis factor receptor superfamily, member 18 |
| 366 | tumor necrosis factor receptor superfamily, member 11a, NFKB activator |
| 367 | tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain |
| 368 | tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain |
| 369 | tumor necrosis factor receptor superfamily, member 10b |
| 370 | tumor necrosis factor receptor superfamily, member 10a |
| 371 | suppressor of cytokine signaling 2 |
| 372 | CASP8 and FADD-like apoptosis regulator |
| 373 | histone deacetylase 3 |
| 374 | immediate early response 3 |
| 375 | Tax1 (human T-cell leukemia virus type I) binding protein 1 |
| 376 | B-cell CLL/lymphoma 10 |
| 377 | peptidoglycan recognition protein 1 |
| 378 | tumor necrosis factor (ligand) superfamily, member 18 |
| 379 | nucleolar protein 3 (apoptosis repressor with CARD domain) |
| 380 | kalirin, RhoGEF kinase |
| 381 | mitogen-activated protein kinase kinase kinase 14 |
| 382 | suppressor of cytokine signaling 3 |
| 383 | DnaJ (Hsp40) homolog, subfamily A, member 3 |
| 384 | apoptosis-inducing factor, mitochondrion-associated, 1 |
| 385 | ATG12 autophagy related 12 homolog (S. cerevisiae) |
| 386 | programmed cell death 5 |
| 387 | estrogen receptor binding site associated, antigen, 9 |
| 388 | death effector domain containing |
| 389 | Fas apoptotic inhibitory molecule 3 |
| 390 | TGFB1-induced anti-apoptotic factor 1 |
| 391 | serine/threonine kinase 17b |
| 392 | serine/threonine kinase 17a |
| 393 | B-cell CLL/lymphoma 7B |
| 394 | thioredoxin-like 1 |
| 395 | glutathione S-transferase omega 1 |
| 396 | lymphocyte antigen 86 |
| 397 | Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 |
| 398 | ATG5 autophagy related 5 homolog (S. cerevisiae) |
| 399 | lipopolysaccharide-induced TNF factor |
| 400 | BCL2-associated athanogene 5 |
| 401 | BCL2-associated athanogene 4 |
| 402 | BCL2-associated athanogene 3 |
| 403 | BCL2-associated athanogene 2 |
| 404 | etoposide induced 2.4 mRNA |
| 405 | tumor protein p53 inducible protein 3 |
| 406 | neuregulin 2 |
| 407 | brain and reproductive organ-expressed (TNFRSF1A modulator) |
| 408 | ring finger protein 7 |
| 409 | TNF receptor-associated factor 4 |
| 410 | metallothionein-like 5, testis-specific (tesmin) |
| 411 | protein phosphatase 1F (PP2C domain containing) |
| 412 | extra spindle pole bodies homolog 1 (S. cerevisiae) |
| 413 | BCL2-associated transcription factor 1 |
| 414 | tumor necrosis factor (ligand) superfamily, member 15 |
| 415 | CASP8 associated protein 2 |
| 416 | v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) |
| 417 | TRAF family member-associated NFKB activator |
| 418 | programmed cell death 6 |
| 419 | BCL2-like 10 (apoptosis facilitator) |
| 420 | BCL2-like 11 (apoptosis facilitator) |
| 421 | fem-1 homolog b (C. elegans) |
| 422 | B-cell receptor-associated protein 31 |
| 423 | non-metastatic cells 6, protein expressed in (nucleoside-diphosphate kinase) |
| 424 | zinc finger protein 443 |
| 425 | survival motor neuron domain containing 1 |
| 426 | TRAF interacting protein |
| 427 | macrophage erythroblast attacher |
| 428 | nucleotide-binding oligomerization domain containing 1 |
| 429 | testis-specific kinase 2 |
| 430 | unc-13 homolog B (C. elegans) |
| 431 | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
| 432 | peroxiredoxin 4 |
| 433 | HIV-1 Tat interactive protein 2, 30kDa |
| 434 | SIVA1, apoptosis-inducing factor |
| 435 | cell growth regulator with ring finger domain 1 |
| 436 | tumor necrosis factor (ligand) superfamily, member 13b |
| 437 | calpain 9 |
| 438 | NCK-associated protein 1 |
| 439 | mitochondrial ribosomal protein S30 |
| 440 | WD repeat domain 3 |
| 441 | mucosa associated lymphoid tissue lymphoma translocation gene 1 |
| 442 | growth arrest and DNA-damage-inducible, gamma |
| 443 | ectodysplasin A receptor |
| 444 | Fas-activated serine/threonine kinase |
| 445 | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide |
| 446 | interleukin 24 |
| 447 | receptor-interacting serine-threonine kinase 3 |
| 448 | Fas (TNFRSF6) associated factor 1 |
| 449 | calpain 11 |
| 450 | programmed cell death 10 |
| 451 | NLR family, pyrin domain containing 1 |
| 452 | caspase recruitment domain family, member 8 |
| 453 | programmed cell death 11 |
| 454 | Fas apoptotic inhibitory molecule 2 |
| 455 | senataxin |
| 456 | tripartite motif-containing 35 |
| 457 | monocyte to macrophage differentiation-associated |
| 458 | mitogen-activated protein kinase 8 interacting protein 2 |
| 459 | zinc finger protein 346 |
| 460 | caspase 14, apoptosis-related cysteine peptidase |
| 461 | apoptosis related protein |
| 462 | death-associated protein kinase 2 |
| 463 | nucleoporin 62kDa |
| 464 | protein phosphatase 1, regulatory (inhibitor) subunit 15A |
| 465 | ADP-ribosylation factor interacting protein 2 (arfaptin 2) |
| 466 | BCL2-like 13 (apoptosis facilitator) |
| 467 | mitochondrial carrier homolog 1 (C. elegans) |
| 468 | tumor necrosis factor, alpha-induced protein 8 |
| 469 | peroxiredoxin 5 |
| 470 | nuclear protein 1 |
| 471 | apoptosis antagonizing transcription factor |
| 472 | nerve growth factor receptor (TNFRSF16) associated protein 1 |
| 473 | cell death-inducing DFFA-like effector b |
| 474 | tumor necrosis factor receptor superfamily, member 21 |
| 475 | programmed cell death 4 (neoplastic transformation inhibitor) |
| 476 | HtrA serine peptidase 2 |
| 477 | melanoma antigen family H, 1 |
| 478 | PYD and CARD domain containing |
| 479 | caspase recruitment domain family, member 10 |
| 480 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13 |
| 481 | angiopoietin-like 4 |
| 482 | chromosome 12 open reading frame 47 |
| 483 | bifunctional apoptosis regulator |
| 484 | tumor necrosis factor receptor superfamily, member 12A |
| 485 | chromosome 2 open reading frame 28 |
| 486 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 41 |
| 487 | GULP, engulfment adaptor PTB domain containing 1 |
| 488 | TRAF and TNF receptor associated protein |
| 489 | peptidyl-tRNA hydrolase 2 |
| 490 | cisplatin resistance-associated overexpressed protein |
| 491 | regulator of telomere elongation helicase 1 |
| 492 | cytochrome c, somatic |
| 493 | spindlin family, member 2A |
| 494 | TRIAD3 protein |
| 495 | zinc finger, RAN-binding domain containing 1 |
| 496 | aprataxin |
| 497 | tumor necrosis factor receptor superfamily, member 19 |
| 498 | NLR family, pyrin domain containing 2 |
| 499 | B-cell receptor-associated protein 29 |
| 500 | diablo homolog (Drosophila) |
| 501 | sphingosine kinase 2 |
| 502 | dual specificity phosphatase 22 |
| 503 | apoptosis, caspase activation inhibitor |
| 504 | reticulon 4 |
| 505 | baculoviral IAP repeat-containing 6 (apollon) |
| 506 | tribbles homolog 3 (Drosophila) |
| 507 | NLR family, CARD domain containing 4 |
| 508 | ICEBERG caspase-1 inhibitor |
| 509 | apoptosis inhibitor |
| 510 | cell death-inducing DFFA-like effector c |
| 511 | p53-regulated apoptosis-inducing protein 1 |
| 512 | PERP, TP53 apoptosis effector |
| 513 | nucleotide-binding oligomerization domain containing 2 |
| 514 | caspase recruitment domain family, member 9 |
| 515 | AXIN1 up-regulated 1 |
| 516 | B-cell CLL/lymphoma 11B (zinc finger protein) |
| 517 | caspase recruitment domain family, member 14 |
| 518 | BCL2-like 14 (apoptosis facilitator) |
| 519 | baculoviral IAP repeat-containing 7 (livin) |
| 520 | PHD finger protein 17 |
| 521 | BCL2-like 12 (proline rich) |
| 522 | programmed cell death 2-like |
| 523 | caspase recruitment domain family, member 11 |
| 524 | caspase recruitment domain family, member 6 |
| 525 | NLR family, pyrin domain containing 12 |
| 526 | baculoviral IAP repeat-containing 8 |
| 527 | NLR family, pyrin domain containing 3 |
| 528 | peptidoglycan recognition protein 2 |
| 529 | exocyst complex component 3-like |
| 530 | myosin XVIIIA |
| 531 | DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 12 (CHL1-like helicase homolog, S. cerevisiae) |
| 532 |
cell division cycle 2-like 2 (PITSLRE proteins) |